The peripheral antinociceptive effect of nalbuphine is associated with activation of ATP-sensitive K+ channels

Proceedings of the Western Pharmacology Society

Volumn 50, Issue , 2007, Pages 72-74

  Ortiz, Mario I ^a   Fernández Martínez, Eduardo ^a   Ponce Monter, Héctor ^a   Pérez Hernández, Nury ^a   Macías, Arturo ^a   Rangel Flores, Eduardo ^a   Castañeda Hérnandez, Gilberto ^b  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; MORPHINE; NALBUPHINE; NARCOTIC ANALGESIC AGENT; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; PAIN ASSESSMENT; PERIPHERAL NERVOUS SYSTEM; RAT; SENSORY NERVE CELL; STATISTICAL ANALYSIS; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYBURIDE; KATP CHANNELS; MORPHINE; NALBUPHINE; NEURONS, AFFERENT; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR;

EID: 48249123454     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Schmidt, W.K., Tam, S.W., Shotzberger, G.S., Smith, D.H. Jr, Clark, R., Vernier, V.G. (1985) Drug Alcohol Depend. 14, 339-362.
2. Hoskin, P.J., Hanks, G.W. (1991) Drugs 41, 326-344.
3. Culebras, X., Gaggero, G., Zatloukal, J., Kern, C., Marti, R.A. (2000) Anesth. Analg. 91, 601-605.
4. Ortiz, M.I., Castro-Olguín, J., Peña-Samaniego, N., Castañeda-Hernández, G. (2005) Pharmacol. Biochem. Behav. 82, 695-703.
5. Ortiz, M.I., Torres-López, J.E., Castañeda-Hernández, G., Rosas, R., Vidal-Cantú, G.C., Granados-Soto, V. (2002) Eur. J. Pharmacol. 438, 85-91.
6. Zimmermann, M. (1983) Pain 16, 109-110.
7. Cadet, P. (2004) Med. Sci. Monit. 10, MS28-MS32.
8. Gutman, G.A., Chandy, K.G., Adelman, J.P., et al. (1993) Pharmacol. Rev. 55, 583-586.
9. Edwards, G., Weston, A.H. (1993) Annu. Rev. Pharmacol. Toxicol. 33, 597-637.
10. Ocaña, M., Cendan, C.M., Cobos, E.J., Entrena, J.M., Baeyens, J.M. (2004) Eur. J. Pharmacol. 500, 203-219.
11. Vergoni, A.V., Scarano, A., Bertolini, A. (1992) Life Sci. 50, PL135-PL138.
12. Ocaña, M., Barrios, M., Baeyens, J.M. (1996) J. Pharmacol. Exp. Ther. 276, 1136-1142.